Clinicians treating HIV infection must balance the need to suppress viral replication against the harmful side effects and significant cost of antiretroviral therapy. Inadequate therapy often results in the emergence of resistant viruses and treatment failure. These difficulties are especially acute in resource-poor settings, where antiretroviral agents are limited. This has prompted an interest in induction–maintenance (IM) treatment strategies, in which brief intensive therapy is used to reduce host viral levels. Induction is followed by a simplified and more easily tolerated maintenance regimen.
http://compbiol.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pcbi.0030133
I would be interested in reading that information.
This actually might change soon, I read something on that just recently.
The idea is to use HAART to get to undetectable VL, and then take "maintenance" treatment to keep it that way (possibly just one or two meds). I would call it FAART )))
This study doesn't present the fact that people on HAART will have to take the drugs for life. Anyone that has taken a vacation from HAART knows that their CD4 levels will drop and their VL will increase. That's the reason the ID doctors no longer recommend med vacations.